| 1 |
32034953 | Higher Systemic Exposure to Unbound Active Metabolites of Regorafenib Is Associated With Short Progression-Free Survival in Colorectal Cancer Patients. | 2020 Sep |
1 |
| 2 |
31058459 | Functional characterization of 27 CYP3A4 protein variants to metabolize regorafenib in vitro. | 2019 Oct |
7 |
| 3 |
31293154 | Characterization of Genetic Variation in CYP3A4 on the Metabolism of Cabozantinib in Vitro. | 2019 Aug 19 |
1 |
| 4 |
27500989 | Regorafenib induced severe toxic hepatitis: characterization and discussion. | 2016 Nov |
2 |
| 5 |
24405315 | Regorafenib for treatment of advanced gastrointestinal stromal tumors. | 2014 Mar |
1 |